KyeongJin Kim

6PUBLICATIONS
22CO-AUTHORS
Gene and molecular therapyMetabolic medicineProteomics and intermolecular interactions (excl. medical proteomics)Genome structure and regulationNanophotonics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 27, 2025
Focus on Semaglutide 2.4 mg/week for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis.

Salvatore Petta, KyeongJin Kim, Giovanni Targher

|Jul 31, 2025
Hepatocyte KCTD17-mediated SERPINA3 inhibition determines liver fibrosis in metabolic dysfunction-associated steatohepatitis.

Yelin Jeong, Ah-Reum Oh, Young Hoon Jung

|Oct 01, 2023
Targeting E3 ubiquitin ligases and their adaptors as a therapeutic strategy for metabolic diseases.

Yelin Jeong, Ah-Reum Oh, Young Hoon Jung

|Jun 24, 2021
Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis.

Junjie Yu, Changyu Zhu, Xiaobo Wang

|Mar 24, 2021
Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver.

KyeongJin Kim, Jin Ku Kang, Young Hoon Jung

Pageof 1